178 related articles for article (PubMed ID: 24967532)
1. Ontogenic profile of seizures evoked by the beta-carboline DMCM (methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate) in rats.
Kulick C; Gutherz S; Kondratyev A; Forcelli PA
Eur J Pharmacol; 2014 Oct; 740():662-8. PubMed ID: 24967532
[TBL] [Abstract][Full Text] [Related]
2. Profile of anticonvulsant action of levetiracetam, tiagabine and phenobarbital against seizures evoked by DMCM (methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate) in neonatal rats.
Kulick CV; Gutherz SB; Beck VC; Medvedeva N; Soper C; Forcelli PA
Eur J Pharmacol; 2014 Nov; 743():63-8. PubMed ID: 25246016
[TBL] [Abstract][Full Text] [Related]
3. Effects of two convulsant beta-carboline derivatives, DMCM and beta-CCM, on regional neurotransmitter amino acid levels and on in vitro D-[3H]aspartate release in rodents.
Chapman AG; Cheetham SC; Hart GP; Meldrum BS; Westerberg E
J Neurochem; 1985 Aug; 45(2):370-81. PubMed ID: 2861248
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent anticonvulsant actions of perampanel and brivaracetam in the methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM) model of seizures in developing rats.
Culjat M; Huizenga MN; Forcelli PA
Pharmacol Rep; 2021 Feb; 73(1):296-302. PubMed ID: 33210244
[TBL] [Abstract][Full Text] [Related]
5. Behavioural and convulsant actions of two methyl esters of beta-carboline-3-carboxylic acid in photosensitive baboons and in DBA/2 mice.
Croucher M; De Sarro G; Jensen L; Meldrum B
Eur J Pharmacol; 1984 Sep; 104(1-2):55-60. PubMed ID: 6499918
[TBL] [Abstract][Full Text] [Related]
6. Interaction of beta-carboline inverse agonists for the benzodiazepine site with another site on GABAA receptors.
Im HK; Im WB; Carter DB; McKinley DD
Br J Pharmacol; 1995 Mar; 114(5):1040-4. PubMed ID: 7780638
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
Klitgaard H; Matagne A; Gobert J; Wülfert E
Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
[TBL] [Abstract][Full Text] [Related]
8. DMCM: a potent convulsive benzodiazepine receptor ligand.
Petersen EN
Eur J Pharmacol; 1983 Oct; 94(1-2):117-24. PubMed ID: 6317396
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant effect of cannabinoid receptor agonists in models of seizures in developing rats.
Huizenga MN; Wicker E; Beck VC; Forcelli PA
Epilepsia; 2017 Sep; 58(9):1593-1602. PubMed ID: 28691158
[TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus properties of methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM), an inverse agonist at benzodiazepine receptors.
Nielsen EB; Jepsen SA; Nielsen M; Braestrup C
Life Sci; 1985 Jan; 36(1):15-23. PubMed ID: 2981379
[TBL] [Abstract][Full Text] [Related]
11. Behavioral evidence for the role of noradrenaline in the putative anxiogenic actions of the inverse benzodiazepine receptor agonist methyl-4-ethyl-6,7-dimethoxy-beta-carboline-3-carboxylate.
Yang XM; Luo ZP; Zhou JH
J Pharmacol Exp Ther; 1989 Jul; 250(1):358-63. PubMed ID: 2545863
[TBL] [Abstract][Full Text] [Related]
12. Differences in the negative allosteric modulation of gamma-aminobutyric acid receptors elicited by 4'-chlorodiazepam and by a beta-carboline-3-carboxylate ester: a study with natural and reconstituted receptors.
Puia G; Santi MR; Vicini S; Pritchett DB; Seeburg PH; Costa E
Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7275-9. PubMed ID: 2476816
[TBL] [Abstract][Full Text] [Related]
13. Benzodiazepine receptors studied in living primates by positron emission tomography: inverse agonist interactions.
Hantraye P; Chavoix C; Guibert B; Fukuda H; Brouillet E; Dodd RH; Prenant C; Crouzel M; Naquet R; Mazière M
Eur J Pharmacol; 1987 Jun; 138(2):239-47. PubMed ID: 3040433
[TBL] [Abstract][Full Text] [Related]
14. Discriminative stimulus properties of the benzodiazepine receptor inverse agonist methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM).
Kirby LG; Rowan GA; Smith RL; Lucki I
Psychopharmacology (Berl); 1994 Jan; 113(3-4):351-60. PubMed ID: 7862845
[TBL] [Abstract][Full Text] [Related]
15. Selective protection by adenosine receptor agonists against DMCM-induced seizures.
Petersen EN
Eur J Pharmacol; 1991 Mar; 195(2):261-5. PubMed ID: 1874275
[TBL] [Abstract][Full Text] [Related]
16. beta-Carboline gamma-aminobutyric acidA receptor inverse agonists modulate gamma-aminobutyric acid via the loreclezole binding site as well as the benzodiazepine site.
Stevenson A; Wingrove PB; Whiting PJ; Wafford KA
Mol Pharmacol; 1995 Dec; 48(6):965-9. PubMed ID: 8848011
[TBL] [Abstract][Full Text] [Related]
17. DMCM, a benzodiazepine site inverse agonist, improves active avoidance and motivation in the rat.
Samardžić J; Strac DŠ; Obradović M; Oprić D; Obradović DI
Behav Brain Res; 2012 Dec; 235(2):195-9. PubMed ID: 22878232
[TBL] [Abstract][Full Text] [Related]
18. Behavioral differences between subgroups of rats with high and low threshold to clonic convulsions induced by DMCM, a benzodiazepine inverse agonist.
Contó MB; de Carvalho JG; Benedito MA
Pharmacol Biochem Behav; 2005 Nov; 82(3):417-26. PubMed ID: 16297441
[TBL] [Abstract][Full Text] [Related]
19. The beta-carboline derivative DMCM decreases gamma-aminobutyric acid responses and Ca(2+)-mediated K(+)-conductance in rat neocortical neurons in vitro.
Capogna M; Berretta N; Berton F; Bianchi R; Brunelli M; Francesconi W
Neuropharmacology; 1994 Jul; 33(7):875-83. PubMed ID: 7969808
[TBL] [Abstract][Full Text] [Related]
20. Different genes specify hyporesponsiveness to seizures induced by caffeine and the benzodiazepine inverse agonist, DMCM.
Seale TW; Abla KA; Roderick TH; Rennert OM; Carney JM
Pharmacol Biochem Behav; 1987 Jul; 27(3):451-6. PubMed ID: 2821552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
